DLB
Dolby Laboratories, Inc.
Key Financials
Revenue
$1.3B
↑ 5.9%
Gross Profit
$1.2B
↑ 4.9%
Net Income
$255.0M
↓ 2.6%
Operating Income
$265.0M
↑ 2.6%
Total Assets
$3.2B
↑ 3.8%
Total Liabilities
$595.8M
↓ 4.4%
EPS (Diluted)
$2.62
↓ 2.6%
Cash & Equivalents
$701.9M
↑ 45.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 8/14/2026 | View on SEC |
| 4 | 8/12/2026 | View on SEC |
| 144 | 8/10/2026 | View on SEC |
| 4 | 8/6/2026 | View on SEC |
| 4 | 8/5/2026 | View on SEC |
| 144 | 8/3/2026 | View on SEC |
| 10-Q | 7/30/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| 4 | 7/6/2026 | View on SEC |
| 144 | 7/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DLB |
| Company Name | Dolby Laboratories, Inc. |
| CIK | 1308547 |
| Sector | Patent Owners & Lessors |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 6794 |
| SIC Description | Patent Owners & Lessors |
| Entity Type | operating |
| Fiscal Year End | 0927 |
| State of Incorporation | DE |
| Phone | 415 558 0200 |